Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (20)

2016

  1. Is microarray analysis really useful and sufficient to diagnose nut allergy in the Mediterranean area?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 1, pp. 31-39

1997

  1. The 80-kD fibronectin fragment increases the production of fibronectin and tumour necrosis factor-alpha (TNF-α) in cultured mesangial cells

    Clinical and Experimental Immunology, Vol. 107, Núm. 2, pp. 398-403

1996

  1. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth

    Hypertension, Vol. 27, Núm. 4, pp. 885-892

  2. Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells

    European Journal of Pharmacology, Vol. 302, Núm. 1-3, pp. 191-197

  3. Urinary excretion of platelet-activating factor in human and experimental nephrosis

    Nephrology Dialysis Transplantation, Vol. 11, Núm. 2, pp. 282-286

1995

  1. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis

    Clinical and Experimental Immunology, Vol. 102, Núm. 3, pp. 608-613

  2. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis.

    Advances in nephrology from the Necker Hospital, Vol. 24, pp. 53-77

  3. Potential factors governing extracellular matrix production by mesangial cells: their relevance for the pathogenesis of IgA nephropathy.

    Contributions to nephrology, Vol. 111, pp. 45-54

1994

  1. Involvement of angiotensin ii and endothelin in matrix protein production and renal sclerosis

    Journal of Hypertension, Vol. 12, pp. S51-S58

  2. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases

    Journal of Lipid Mediators and Cell Signalling, Vol. 9, Núm. 1, pp. 55-74

1993

  1. Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy.

    Contributions to nephrology, Vol. 104, pp. 127-137

1992

  1. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor

    European Journal of Pharmacology, Vol. 224, Núm. 2-3, pp. 167-172

1991

  1. IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates

    Lipids, Vol. 26, Núm. 12, pp. 1231-1235

1990

  1. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response

    Journal of Lipid Mediators

  2. The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage

    Revista clínica española, Vol. 187, Núm. 3, pp. 137-143

1989

  1. Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy

    Immunology, Vol. 67, Núm. 3, pp. 308-313

  2. Interstitial Mononuclear Cell Infiltrates in Experimental Nephrosis: Effect of PAF Antagonist

    Nephrology Dialysis Transplantation, Vol. 4, Núm. 12, pp. 1037-1044

1987

  1. Immunological studies of experimental IgA nephropathy in mice.

    Advances in experimental medicine and biology, Vol. 216 B, pp. 1583-1591

  2. Role of platelet-activating factor in adriamycin-induced nephropathy in rats

    European Journal of Pharmacology, Vol. 138, Núm. 1, pp. 119-123

1986

  1. The importance of the Fc receptors for IgA in the recognition of IgA by mouse liver cells: Its comparison with carbohydrate and secretory component receptors

    Immunology, Vol. 57, Núm. 1, pp. 37-42